MoneyWorks4Me

Procter&Gamble Healt - Quaterly Results

01 Aug 2025 Evaluate
The June 2025 quarter revenue stood at Rs. 3387.40 millions, up 19.33% as compared to Rs. 2838.80 millions during the corresponding quarter last year.Net Profit for the quarter ended June 2025 zoomed to 294.40% from Rs. 167.80 millions to Rs. 661.80  millions.OP of the company witnessed a marginal growth to 943.70 millions from 503.80 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202406 202306 % Var
Sales 3387.40 2838.80 19.33 12729.10 11512.60 10.57 11512.60 12296.20 -6.37
Other Income 40.30 21.30 89.20 143.80 156.30 -8.00 156.30 183.90 -15.01
PBIDT 943.70 503.80 87.32 4231.10 3216.30 31.55 3216.30 3430.70 -6.25
Interest 1.20 2.00 -40.00 5.50 7.20 -23.61 7.20 7.70 -6.49
PBDT 942.50 299.90 214.27 4225.60 3007.20 40.52 3007.20 3423.00 -12.15
Depreciation 54.40 71.60 -24.02 221.30 274.00 -19.23 274.00 281.00 -2.49
PBT 888.10 228.30 289.01 4004.30 2733.20 46.51 2733.20 3142.00 -13.01
TAX 226.30 60.50 274.05 998.40 723.40 38.01 723.40 847.30 -14.62
Deferred Tax -3.10 -67.40 -95.40 -8.00 -86.00 -90.70 -86.00 -50.60 69.96
PAT 661.80 167.80 294.40 3005.90 2009.80 49.56 2009.80 2294.70 -12.42
Equity 166.00 166.00 0.00 166.00 166.00 0.00 166.00 166.00 0.00
PBIDTM(%) 27.86 17.75 56.98 33.24 27.94 18.98 27.94 27.90 0.13
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..